Triamcinolone aminobenzal benzamidoisobutyrate
| Triamcinolone aminobenzal benzamidoisobutyrate | |
|---|---|
| Triamcinolone_aminobenzal_benzamidoisobutyrate.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Triamcinolone aminobenzal benzamidoisobutyrate is a synthetic corticosteroid used in the treatment of various inflammatory and allergic conditions. It is a derivative of triamcinolone, a potent glucocorticoid with anti-inflammatory and immunosuppressive properties.
Pharmacology[edit]
Triamcinolone aminobenzal benzamidoisobutyrate functions by modulating the body's immune response to reduce inflammation. As a glucocorticoid, it binds to specific glucocorticoid receptors in the body, influencing the transcription of anti-inflammatory proteins and inhibiting the expression of pro-inflammatory cytokines.
Medical uses[edit]
This compound is primarily used in the management of conditions such as allergic rhinitis, asthma, and dermatitis. It may also be prescribed for other inflammatory disorders where corticosteroid therapy is indicated.
Side effects[edit]
Common side effects of triamcinolone aminobenzal benzamidoisobutyrate include skin irritation, dryness, and itching at the site of application. Systemic absorption can lead to more serious effects such as adrenal suppression, osteoporosis, and hyperglycemia.
Mechanism of action[edit]
The mechanism of action involves the suppression of inflammatory pathways by inhibiting the migration of leukocytes and reversing capillary permeability. This results in decreased edema, erythema, and itching associated with inflammatory skin conditions.
Related pages[edit]
References[edit]
Triamcinolone aminobenzal benzamidoisobutyrate[edit]
-
Triamcinolone aminobenzal benzamidoisobutyrate
